1. Home
  2. NRIX vs LZB Comparison

NRIX vs LZB Comparison

Compare NRIX & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.40

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$35.79

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRIX
LZB
Founded
2009
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
NRIX
LZB
Price
$16.40
$35.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
1
Target Price
$30.50
$39.00
AVG Volume (30 Days)
820.0K
322.5K
Earning Date
04-08-2026
06-16-2026
Dividend Yield
N/A
2.75%
EPS Growth
N/A
N/A
EPS
N/A
1.65
Revenue
$76,987,000.00
$2,349,433,000.00
Revenue This Year
N/A
$1.89
Revenue Next Year
$48.05
$2.09
P/E Ratio
N/A
$21.48
Revenue Growth
99.31
N/A
52 Week Low
$8.20
$29.03
52 Week High
$22.50
$44.49

Technical Indicators

Market Signals
Indicator
NRIX
LZB
Relative Strength Index (RSI) 50.24 56.82
Support Level $16.02 $35.32
Resistance Level $16.71 $39.79
Average True Range (ATR) 0.76 0.90
MACD -0.07 -0.02
Stochastic Oscillator 36.24 66.62

Price Performance

Historical Comparison
NRIX
LZB

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: